Difference between revisions of "Part:BBa K3142005"
| Line 3: | Line 3: | ||
<partinfo>BBa_K3142005 short</partinfo> | <partinfo>BBa_K3142005 short</partinfo> | ||
| − | Angiotensin-converting enzyme in hypoallergenic infant milk formulas, which is a highly active hypotensive peptide.The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used. | + | Angiotensin-converting enzyme in hypoallergenic infant milk formulas, which is a highly active hypotensive peptide.The sequence has been optimized for ''lactic acid bacteria''. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
Latest revision as of 12:49, 21 October 2019
Antihypertensive dipeptide（VY）
Angiotensin-converting enzyme in hypoallergenic infant milk formulas, which is a highly active hypotensive peptide.The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
- Martin, M., A. Wellner, I. Ossowski, and T. Henle. 2008. Identification and quantification of inhibitors for Angiotensin-converting enzyme in hypoallergenic infant milk formulas.[J] Agric Food Chem 56:6333–6338.